Center for European Policy Analysis Issues Commentary: National Security Risk - Biotech
April 14, 2026
April 14, 2026
WASHINGTON, April 14 -- The Center for European Policy Analysis issued the following commentary on April 13, 2026, by senior resident fellow Elly Rostoum:
* * *
The New National Security Risk: Biotech
Both the US and Europe are embedding biotech data into national security policy.
*
In December 2025, the US Congress passed the BIOSECURE Act, reclassifying human biological data as a strategic asset and a national security priority. . . .
* * *
The New National Security Risk: Biotech
Both the US and Europe are embedding biotech data into national security policy.
*
In December 2025, the US Congress passed the BIOSECURE Act, reclassifying human biological data as a strategic asset and a national security priority. . . .